In Patients with Early Peripheral Psoriatic Arthritis Baseline C-Reactive Protein, Pain and Ultrasound-Detected Synovitis Predict Subsequent Treatment with ts/bDMARDs. A Retrospective Analysis
With the availability of effective treatment with targeted synthetic and biologic disease-modifying anti-rheumatic drugs (ts/bDMARDs) for psoriatic arthritis (PsA), it is crucial to identify predictors of access to this treatment since disease onset. We retrospectively enrolled patients with periphe...
Main Authors: | Garifallia Sakellariou, Silvana Quaglini, Serena Bugatti, Francesca Bobbio-Pallavicini, Vittorio Gabba, Carlomaurizio Montecucco |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-06-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/10/13/2834 |
Similar Items
-
Psoriatic Synovitis: Singularity and Potential Clinical Implications
by: Raquel Celis, et al.
Published: (2019-02-01) -
Psoriatic arthritis: treatment strategies using anti-inflammatory drugs and classical DMARDs
by: E. Lubrano, et al.
Published: (2012-06-01) -
Psoriatic Arthritis of TMJ Presenting as a First Articular Complaint in Psoriasis
by: B Vijay Kumar, et al.
Published: (2011-01-01) -
IS PSORIATIC ARTHRITIS REALLY PSORIATIC?
by: Sh. F. Erdes
Published: (2014-12-01) -
The efficacy and tolerability of leflunomide (Arava®) in therapy for psoriatic arthritis
by: Vladimir Vasilyevich Badokin
Published: (2013-12-01)